MARATTO

article · Microchemical Journal

Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment

In plain language

No abstract is available for this record, so no summary has been generated.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.microc.2025.116041

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.